Benefit of Whole Pelvic Radiotherapy Combined With Neoadjuvant Androgen Deprivation for the High-Risk Prostate Cancer

Journal of Biomedicine and Biotechnology
doi 10.1155/2009/625394
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Combined Brachytherapy and External Beam Radiotherapy Without Adjuvant Androgen Deprivation Therapy for High-Risk Prostate Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2014English

Use of Androgen Deprivation Therapy With Radiotherapy for Intermediate- And High-Risk Prostate Cancer Across the United States

JAMA Oncology
Cancer ResearchOncology
2016English

High-Dose Radiation Employing External Beam Radiotherapy and High-Dose Rate Brachytherapy With and Without Neoadjuvant Androgen Deprivation for Prostate Cancer Patients With Intermediate- And High-Risk Features

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2006English

Is Neoadjuvant Androgen Deprivation Therapy Necessary for Patients With Intermediate-Risk Prostate Cancer Treated With Proton Therapy?

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Risk of the "Androgen Deprivation Syndrome" in Men Receiving Androgen Deprivation for Prostate Cancer

Archives of Internal Medicine
2006English

MR-Guided Pulsed High-Intensity Focused Ultrasound Enhancement of Gene Therapy Combined With Androgen Deprivation and Radiotherapy for Prostate Cancer Treatment

2009English

Stereotactic Body-Radiotherapy Boost Dose of 18 Gy vs 21 Gy in Combination With Androgen-Deprivation Therapy and Whole-Pelvic Radiotherapy for Intermediate- Or High-Risk Prostate Cancer: A Study Protocol for a Randomized Controlled, Pilot Trial

Trials
MedicinePharmacology
2018English

Androgen Deprivation Therapy for Prostate Cancer and Risk of Dementia

BJU International
Urology
2019English

Androgen Deprivation Therapy for Prostate Cancer

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy